Research output: Contribution to journal › Article › peer-review
Journal | Nature immunology |
---|---|
Date | Accepted/In press - 11 Aug 2020 |
Date | E-pub ahead of print - 4 Sep 2020 |
Date | Published (current) - Nov 2020 |
Issue number | 11 |
Volume | 21 |
Pages (from-to) | 1336–1345 |
Early online date | 4/09/20 |
Original language | English |
The development of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines and therapeutics will depend on understanding viral immunity. We studied T cell memory in 42 patients following recovery from COVID-19 (28 with mild disease and 14 with severe disease) and 16 unexposed donors, using interferon-γ-based assays with peptides spanning SARS-CoV-2 except ORF1. The breadth and magnitude of T cell responses were significantly higher in severe as compared with mild cases. Total and spike-specific T cell responses correlated with spike-specific antibody responses. We identified 41 peptides containing CD4+ and/or CD8+ epitopes, including six immunodominant regions. Six optimized CD8+ epitopes were defined, with peptide-MHC pentamer-positive cells displaying the central and effector memory phenotype. In mild cases, higher proportions of SARS-CoV-2-specific CD8+ T cells were observed. The identification of T cell responses associated with milder disease will support an understanding of protective immunity and highlights the potential of including non-spike proteins within future COVID-19 vaccine design.
© The Author(s), under exclusive licence to Springer Nature America, Inc. 2020. This is an author-produced version of the published paper. Uploaded in accordance with the publisher’s self-archiving policy. Further copying may not be permitted; contact the publisher for details.
Find related publications, people, projects, datasets and more using interactive charts.